Tag Archives: leaving

FDA’s second-in-command Abernethy leaving agency as Biden’s commissioner yet to be named

After just two years at the FDA, principal deputy chief Amy Abernethy is leaving the agency. As second-in-command and acting chief information officer, Abernethy oversaw tech and data modernization at the FDA and launched its COVID-19 accelerator project to boost real-world data gathering. Her unexpected departure comes as the search for a permanent FDA commissioner continues two… Read More »

Top tips for coping as Leaving Cert 2020 chaos fuels anger and anxiety for students

LEAVING Cert 2020 has been a rollercoaster of uncertainty. The announcement by the Department of Education and Skills that there were errors in the grading system, which will lead to about 10pc of students having their grades marked upwards, comes as yet another sharp twist on that rollercoaster. he disappointment some students may have felt… Read More »

WCLC: Roche’s Tecentriq comes up short in squamous lung cancer, leaving Merck’s Keytruda ‘unchallenged’

Roche has been hoping its Tecentriq could put up the kind of life-lengthening numbers in squamous non-small cell lung cancer (NSCLC) that could help it compete with Merck’s Keytruda—but no dice. The Swiss drugmaker Tuesday unveiled results showing that its Tecentriq-chemo combo failed to outdo solo chemo at extending the lives of previously untreated patients.… Read More »